Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2010
12/02/2010WO2010137351A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/02/2010WO2010137350A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010WO2010137349A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010WO2010137336A1 NOVEL α-PHENOXYBENZENEACETIC ACID DERIVATIVE AND PHARMACEUTICAL PREPARATION COMPRISING SAME
12/02/2010WO2010136546A1 3-alkyl-5-fluoroindole derivatives as myeloperoxidase inhibitors
12/02/2010WO2010136508A2 Stem cell targeting
12/02/2010WO2010136500A1 Process for the production of benzofurans
12/02/2010WO2010136137A1 Substituted piperidines
12/02/2010WO2010119346A3 Herbal compositions and methods for enhancing vital energy and athletic performance
12/02/2010WO2010103547A3 Substituted fused pyrimidine compounds
12/02/2010WO2010057028A3 Treatment of proteinopathies using a farnesyl transferase inhibitor
12/02/2010WO2010043950A3 Propafenone extended release composition
12/02/2010US20100305500 Hyaluronidase as an adjuvant for increasing the injection volume and dispersion of large diameter synthetic membrane vesicles containing a therapeutic agent
12/02/2010US20100305213 Treatment of heart disease using beta-blockers
12/02/2010US20100305212 Therapeutic compounds
12/02/2010US20100305208 Gastric retention controlled drug delivery system
12/02/2010US20100305207 Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof
12/02/2010US20100305205 Composition and/or method for preventing recurrence of stroke
12/02/2010US20100305195 microrna mediator of cardiomyopathy and heart failure
12/02/2010US20100305164 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases
12/02/2010US20100305162 Methods for the Synthesis of Pyridoxamine
12/02/2010US20100305156 Inhibitors of c-met protein kinase
12/02/2010US20100305144 Prevention of recurrence of urethral stricture after a conventional treatment
12/02/2010US20100305135 Ahcy hydrolase inhibitors for treatment of hyper homocysteinemia
12/02/2010US20100305131 Substituted Aminopropionic Derivatives as Neprilysin inhibitors
12/02/2010US20100305123 Class of histone deacetylase inhibitors
12/02/2010US20100305116 Compounds Comprising a Cyclobutoxy Group
12/02/2010US20100305114 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues
12/02/2010US20100305113 Substituted Imidazopyridazines as Lipid Kinase Inhibitors
12/02/2010US20100305110 Condensed imidazole derivatives as aldosterone synthase inhibitors
12/02/2010US20100305106 Inhibitors of fatty acid uptake and methods of use
12/02/2010US20100305105 Phenylsulfoxyoxazole compound inhibitors of urea transporters
12/02/2010US20100305104 Oxadiazole Diaryl Compounds
12/02/2010US20100305096 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010US20100305094 Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha
12/02/2010US20100305092 Triazole oxadiazoles derivatives
12/02/2010US20100305089 Fused Bicycloheterocycle Substituted Azabicyclic Alkane Derivatives
12/02/2010US20100305086 Pharmaceutical Compositions for the Treatment of Pain
12/02/2010US20100305085 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
12/02/2010US20100305084 Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010US20100305083 Substituted porphyrins
12/02/2010US20100305081 Organo-gel formulations for therapeutic applications
12/02/2010US20100305079 Method of Treating Human Preeclampsia Employing Resibufagenin
12/02/2010US20100305071 Methods for improving healing of an oral lesion using a glycerophosphate salt
12/02/2010US20100305070 Treatment or prophylaxis of proliferative conditions
12/02/2010US20100305066 Fused Thiophene Derivatives as Kinase Inhibitors
12/02/2010US20100305052 Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof
12/02/2010US20100305034 Growth factor isoform
12/02/2010US20100305031 Peptide having an extending action for half-life of object peptide in plasma
12/02/2010US20100305024 Methods of inhibiting calcineurin with apoe analogs
12/02/2010US20100303928 Isoxazolopyridine derivatives for use in the treatment of hif-mediated conditions
12/02/2010US20100303926 Organic compounds
12/02/2010US20100303924 Process for Producing A Beverage Comprising Cocoa Material with Enhanced Polyphenol Levels
12/02/2010US20100303921 Pharmaceutical Compositions Comprising Cereal Beta (1-3) Beta (1-4) Glucan
12/02/2010US20100303909 Preparation for treating heart disease used in cell therapy
12/02/2010US20100303906 Solid dosage forms of valsartan and amlodipine and method of making same
12/02/2010US20100303896 5beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis
12/02/2010US20100303823 Human monoclonal antibodies against interleukin 8 (il-8)
12/02/2010US20100303807 Methods for the treatment of il-1beta related diseases
12/02/2010US20100303800 Methods and compositions for treating ischemia
12/02/2010US20100303793 Combination therapy for cardiac revascularization and cardiac repair
12/02/2010US20100303790 Use of biliverdin reductase (bvr) and bvr peptide fragments to treat coronary disorders
12/02/2010US20100303769 Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
12/02/2010US20100303768 Isolated lineage negative hematopoietic stem cells and methods of treatment therewith
12/02/2010US20100303754 Process for preparation of cyclodextrin oligomers or polymers, products obtained and uses
12/02/2010US20100303753 Oligomer Conjugates of Lidocaine and Its Derivatives
12/02/2010US20100303741 Wolfberries and inflammation
12/02/2010US20100303726 Humanized collagen antibodies and related methods
12/02/2010US20100303723 Drug delivery systems using fc fragments
12/02/2010DE102009022892A1 Substituierte Piperidine Substituted piperidines
12/02/2010DE102008033254B4 Verfahren zur Herstellung eines einphasischen pharmazeutischen Präparates zur oralen Therapie der Regulierung des Blutdruckes A method for producing a pharmaceutical preparation for the oral therapy einphasischen the regulation of blood pressure
12/02/2010CA2763647A1 Methods of using krill oil to treat risk factors for metabolic, cardiovascular, and inflammatory disorders
12/02/2010CA2763472A1 Process for the production of benzofurans
12/02/2010CA2763446A1 Stem cell targeting
12/02/2010CA2763381A1 Substituted piperidines
12/02/2010CA2763161A1 Cardiovascular related uses of il-1.beta. antibodies and binding fragments thereof
12/02/2010CA2762620A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010CA2762474A1 Method of providing neuroprotection using substituted porphyrins
12/02/2010CA2761639A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/02/2010CA2761597A1 Anti-shock agent comprising diaminotrifluoromethylpyridine derivative
12/02/2010CA2761445A1 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/01/2010EP2256201A2 Modulation of eIF4E expression
12/01/2010EP2256199A1 Therapeutic uses of BR43X2 soluble receptors
12/01/2010EP2256190A1 Method of diagnosing risk of myocardial infarction
12/01/2010EP2256115A1 Heteromonocyclic compound and use thereof
12/01/2010EP2256109A1 Apoptosis inhibitor
12/01/2010EP2256105A1 Novel tetrahydroisoquinoline derivative
12/01/2010EP2255804A1 A pharmaceutical composition and the application thereof in the preparation of medicine for the treatment of cerebrovascular diseases
12/01/2010EP2255668A2 Production and Use of a Polar Lipid-Rich Fraction Containing Omega-3 and/or Omega-6 Highly Unsaturated Fatty Acids from Microbes, Genetically Modified Plant Seeds and Marine Organisms
12/01/2010EP2254881A1 Chlorothiophene-amides as inhibitors of coagulation factors xa and thrombin
12/01/2010EP2254861A1 The 1,3-disubstituted ureas, method of re aration and utilisation thereof
12/01/2010EP2254860A1 Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the b2 adrenergic receptor
12/01/2010EP2254597A2 Methods of treatment using anti-mif antibodies
12/01/2010EP2254578A2 Combination of a carbostyril and carnitine
12/01/2010EP2254563A2 Pharmaceutical combinations comprising specified age breaker and further drugs, i.a. antihypertensive drugs, antidiabetic drugs etc
12/01/2010EP2102164B1 Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives
12/01/2010EP1923065B1 Cholesterol absorption inhibitor
12/01/2010EP1853271B1 Method and composition for treating peripheral vascular diseases
12/01/2010EP1806141B1 Par-2 antagonists
12/01/2010EP1244790B1 Nucleic acids encoding polypeptides having chips activity
1 ... 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 ... 1595